Hilda Kovács

Hilda Kovács

Auto-generated profile, based on publicly available information

Hilda Kovács

Department of Molecular and Analytical Chemistry University of Szeged Szeged Hungary

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2026 in Dalton Transactions
Verified
Journal Article
Open access
PDF file
HKHilda Kovács
Hilda Kovács
ODOrsolya Dömötör
Orsolya Dömötör
AGAnett Giricz
Anett Giricz
NINóra Igaz
Nóra Igaz
KSKrisztina Szőke
Krisztina Szőke
EEEva Anna Enyedy
Eva Anna Enyedy
Herein, the chemical properties of 5-carboxy-8-hydroxyquinoline (IOX1), a histone lysine demethylase KDM4 inhibitor, were comprehensively characterized in aqueous solution, including its complex formation equilibria with essential metal ions such as Fe(II), Fe(III), and Cu(II). IOX1 shows the following metal ion preference at pH 7.4: Fe(II) < Fe(III) < Cu(II). Compared to 2oxoglutarate, the natural substrate of KDM4, IOX1 exhibits a higher affinity for both iron ions. The Rh(III)(η5-C5Me5) (RhCp*) complex of IOX1 was synthesized and characterized by UV-visible, NMR, and mass spectrometry techniques, showing high stability in aqueous solution without the dissociation of IOX1 over a wide pH range and strong interaction with human serum albumin. To access the potential benefits of nanocapsulation, IOX1-loaded anionic clay (LDH) nanoparticles (LDH/IOX1) were successfully synthesized. The anticancer properties of IOX1, its RhCp* complex, and LDH/IOX1 were evaluated in human cancer cell lines. The RhCp* complex exhibited a greater antiproliferative activity toward Colo205 cells than IOX1 alone, and all tested compounds significantly decreased the mitochondrial membrane potential. The LDH/IOX1 system also showed pronounced cytotoxicity on A549 cells, accompanied by strong mitochondrial impairment, indicating the potential of nanocapsulation of small-molecule enzyme inhibitors in cancer therapy.

16 May 2026 in Chemistry – A European Journal
Verified
Journal Article
Closed access
KKKatarzyna Kulik
Katarzyna Kulik
EWEwelina Wielgus
Ewelina Wielgus
MCMichelangelo Cocchioni
Michelangelo Cocchioni
HKHilda Kovács
Hilda Kovács
EEEva Anna Enyedy
Eva Anna Enyedy
BNBarbara Nawrot
Barbara Nawrot

6 August 2026 in Inorganic Chemistry
Verified
Journal Article
Closed access
HKHilda KovácS
Hilda KovácS
LCLeonor CôrTe-Real
Leonor CôrTe-Real
NMNórA V. May
NórA V. May
EKÉvA KovátS
ÉvA KovátS
MZMichal Zalibera
Michal Zalibera
EEEva Anna Enyedy
Eva Anna Enyedy